FDA label
What is dihydroergotamine used for?
The FDA-approved uses of dihydroergotamine, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Dihydroergotamine Mesylate Injection is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted dihydroergotamine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Dihydroergotamine Mesylate, injection
Indications and Usage, quoted from the label by Gland Pharma Limited (ANDA215623). Cross-references to other label sections are left out.
Dihydroergotamine Mesylate Injection is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.
Source: DailyMed label, set id 07a9112c-8c04-4849-8cb3-9463f58731d2, version 7, effective August 22, 2023. NDC 68083-466, one of 3 listings for this product.
Dihydroergotamine Mesylate, spray
Indications and Usage, quoted from the label by Advagen Pharma Ltd (ANDA216881). Cross-references to other label sections are left out.
Dihydroergotamine mesylate nasal spray is indicated for the acute treatment of migraine headaches with or without aura.
Dihydroergotamine mesylate nasal spray is not intended for the prophylactic therapy of migraine or for the management of hemiplegic or basilar migraine.
Source: DailyMed label, set id 65f8c60d-9213-48ac-8233-acc5d44548f4, version 4, effective January 7, 2026. NDC 72888-096, one of 3 listings for this product.
Questions
What is dihydroergotamine used for?
The FDA label says: “Dihydroergotamine Mesylate Injection is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.”
What drug class is dihydroergotamine?
FDA lists dihydroergotamine in the Ergotamine Derivative established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Dihydroergotamine
- Is Dihydroergotamine a controlled substance?Federal schedule
- Generic for D.h.e.FDA Orange Book
- Generic for AtzumiFDA Orange Book
- Generic for Brekiya (autoinjector)FDA Orange Book
- Generic for MigranalFDA Orange Book
- Generic for TrudhesaFDA Orange Book
- Ergotamine Derivatives listFDA drug class
- NDC 64896-509Dihydroergotamine NDC record
- NDC 76978-101Dihydroergotamine NDC record
- NDC 77530-725Dihydroergotamine NDC record